Tumor Types Drive Oncology Product Launch Strategies

Unlike traditional launch plans designed for blockbuster products, oncology and hematology therapy commercialization requires agility.

• Different tumor types and the form of therapy require distinct commercialization strategies.
• Patients with lung, breast, or colon cancer often undergo long-term, multi-faceted treatment following early detection, requiring sustained patient services and financial support. In contrast, pancreatic cancer patients typically face urgent needs due to late-stage diagnosis.

At EVERSANA, we developed a life sciences commercialization model specific to product and patient needs using a system of archetypes that consider therapy type, how the product is administered and the impact of the therapy on the patient journey.

Leveraging our award-winning model commercialization model, coupled with our deep bench of oncology experts, EVERSANA ONCOLOGY partners with manufacturers to develop a customized, comprehensive go-to-market strategy. Click here to learn more about EVERSANA ONCOLOGY Commercialization^®.